LONCAR Cancer ETF

LONCAR Cancer ETF
  • Pininvest Analysis

 

The Loncar Cancer Immunotherapy ETF is made up of a basket of companies that develop therapies to treat cancer by harnessing the body’s own immune system.

Immunotherapy is a transformational field within the biotechnology space that may have a foundational impact on cancer care.

By developing immunotherapies that are more effective and may deliver a better quality of life than currently available medicines, innovative immunotherapy companies may be making a difference for courageous patients who battle cancer.

Loncar ETF seeks to support this important work and its positive impact on society

The complete list of 25 CNCR constitutents presented in the theme is not weighted; performance and volatility are calculated for informative purpose only - assuming one share of each component had been invested at the beginning of the selected period

More about LONCAR CNCR, the Cancer Immunotherapy ETF

LONCAR Cancer ETF • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Risk Contrib. MDD
 
Adaptimmune Therapeutics ADAP NASDAQ Health Care Biopharmaceuticals USD 3.67 385 M -72.4% 78%   2% -74%
Aduro Biotech ADRO NASDAQ Health Care Biopharmaceuticals USD 3.20 239 M -60.7% 88%   2% -73%
Arcus Biosciences RCUS NYSE Health Care Clinical trial work USD 8.96 399 M -44.9% 65%   3% -47%
Astrazeneca PLC (ADR) AZN NYSE Health Care Drug Manufacturers - Diversified USD 39.02 99 B 9.1% 22%   1% -14%
Atara Biotherapeutics ATRA NASDAQ Health Care Biopharmaceuticals USD 23.21 1.1 B -53.8% 67%   3% -54%
BeiGene, Ltd BGNE NASDAQ Health Care Gene Editing - Cell Therapies USD 126.61 7.6 B -33.3% 55%   3% -51%
bluebird bio, Inc. BLUE NASDAQ Health Care Biopharmaceuticals USD 122.86 6.8 B -34.7% 54%   4% -54%
Bristol-Myers Squibb Company BMY NYSE Health Care Drug Manufacturers - Diversified USD 46.81 77 B -8.2% 28%   2% -29%
Cellectis SA CLLS NASDAQ Health Care Biopharmaceuticals USD 17.19 729 M -44.4% 41%   2% -50%
CytomX Therapeutics CTMX NASDAQ Health Care Biopharmaceuticals USD 11.07 502 M -57.8% 73%   3% -65%
Dynavax Technologies DVAX NASDAQ Health Care Biopharmaceuticals USD 5.78 370 M -65.5% 60%   2% -65%
Fate Therapeutics FATE NASDAQ Health Care Biopharmaceuticals USD 18.97 1.2 B 65.1% 72%   15% -32%
Five Prime Therapeutics FPRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 9.05 326 M -51.1% 56%   3% -56%
Gilead Sciences Inc. GILD NASDAQ Health Care Biopharmaceuticals USD 66.89 85 B 2.7% 24%   2% -23%
Iovance Biotherapeutics IOVA NASDAQ Health Care Biopharmaceuticals USD 17.25 2.1 B 8.2% 80%   9% -58%
MacroGenics MGNX NASDAQ Health Care Biopharmaceuticals USD 18.85 920 M -16.9% 99%   6% -53%
Merck & Company MRK NYSE Health Care Drug Manufacturers - Diversified USD 81.17 209 B 40.9% 18%   2% -12%
Mirati Therapeutics, Inc. MRTX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 76.74 2.7 B 73.0% 64%   12% -49%
MorphoSys MOR NASDAQ Health Care Biopharmaceuticals USD 26.41 3.4 B -1.5% 54%   4% -38%
Nektar Therapeutics NKTR NASDAQ Health Care Clinical trial work USD 33.79 5.9 B -57.7% 79%   2% -66%
Novartis NVS NYSE Health Care Drug Manufacturers - Diversified USD 87.52 202 B 32.7% 22%   2% -22%
Sorrento Therapeutics SRNE NASDAQ Health Care Biopharmaceuticals USD 3.50 428 M -55.4% 96%   3% -77%
Xencor XNCR NASDAQ Health Care Clinical trial work USD 32.84 1.9 B -17.2% 52%   5% -42%
ZIOPHARM Oncology ZIOP NASDAQ Health Care Biopharmaceuticals USD 4.22 685 M -6.4% 81%   7% -67%
Zymeworks ZYME NYSE Health Care Clinical trial work USD 17.64 565 M -13.0% 56%   4% -50%